Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain
ABSTRACT Neuropathic pain from injury to the peripheral and CNS represents a major health care issue. We have investigated the role of IL‐33/IL‐33 receptor (ST2) signaling in experimental models of neuropathic pain in mice. Chronic constriction injury (CCI) of the sciatic nerve induced IL‐33 product...
Gespeichert in:
Veröffentlicht in: | The FASEB journal 2016-01, Vol.30 (1), p.54-65 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 65 |
---|---|
container_issue | 1 |
container_start_page | 54 |
container_title | The FASEB journal |
container_volume | 30 |
creator | Zarpelon, Ana C. Rodrigues, Francielle C. Lopes, Alexandre H. Souza, Guilherme R. Carvalho, Thacyana T. Pinto, Larissa G. Xu, Damo Ferreira, Sergio H. Alves‐Filho, Jose C. McInnes, Iain B. Ryffel, Bernhard Quesniaux, Valérie F. J. Reverchon, Flora Mortaud, Stéphane Menuet, Arnaud Liew, Foo Y. Cunha, Fernando Q. Cunha, Thiago M. Verri, Waldiceu A. |
description | ABSTRACT
Neuropathic pain from injury to the peripheral and CNS represents a major health care issue. We have investigated the role of IL‐33/IL‐33 receptor (ST2) signaling in experimental models of neuropathic pain in mice. Chronic constriction injury (CCI) of the sciatic nerve induced IL‐33 production in the spinal cord. IL‐33/citrine reporter mice revealed that oligodendrocytes are the main cells expressing IL‐33 within the spinal cord together with a minor expression by neurons, microglia, and astrocytes. CCI‐induced mechanical hyperalgesia was reduced in IL‐33R (ST2)‐/‐ mice compared with wild‐type (WT) mice. Intrathecal treatment of WT mice with soluble IL‐33 receptor (IL‐33 decoy receptor) markedly reduced CCI‐induced hyperalgesia. Consistent with these observations, intrathecal injection of IL‐33 enhanced CCI hyperalgesia and induced hyperalgesia in naive mice. IL‐33‐mediated hyperalgesia during CCI was dependent on a reciprocal relationship with TNF‐α and IL‐1β. IL‐33‐induced hyperalgesia was markedly attenuated by inhibitors of PI3K, mammalian target of rapamycin, MAPKs (p38, ERK, and JNK), NF‐κB, and also by the inhibitors of glial cells (microglia and astrocytes). Furthermore, targeting these signaling pathways and cells inhibited IL‐33‐induced TNF‐α and IL‐1β production in the spinal cord. Our study, therefore, reveals an important role of oligodendrocyte‐derived IL‐33 in neuropathic pain.— Zarpelon, A. C., Rodrigues, F. C., Lopes, A. H., Souza, G. R., Carvalho, T. T., Pinto, L. G., Xu, D., Ferreira, S. H., Alves‐Filho, J. C., McInnes, I. B., Ryffel, B., Quesniaux, V. F. J., Reverchon, F., Mortaud, S., Menuet, A., Liew, F. Y., Cunha, F. Q., Cunha, T. M., Verri, Jr., W. A. Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain. FASEB J. 30, 54‐65 (2016). www.fasebj.org |
doi_str_mv | 10.1096/fj.14-267146 |
format | Article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03806178v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808690069</sourcerecordid><originalsourceid>FETCH-LOGICAL-h2568-1791acda3da4057a8c4eb9d23566280f75803406485bae7dc50c48d38eef854f3</originalsourceid><addsrcrecordid>eNqFkU1PwkAQhjdGI4jePJse9VCc_ZpOj2pESUg4oOfN0t3KktLWFjTc_An-Rn-JIOjV0yTvPJlM3oexcw59Dile5_M-V7HAhCs8YF2uJcRICIesC5SKGFFSh5207RwAOHA8Zh2BkoNA6rLxpA6lLaKsalxUFeGlcr50TZWtl_7r49P5Jrx5F9nCNotQRsPRJpQyWngX7NK3UelXTVXb5SxkUW1DecqOclu0_mw_e-x5cP909xiPxg_Du5tRPBMaKeZJym3mrHRWgU4sZcpPUyekRhQEeaIJpAJUpKfWJy7TkClykrzPSatc9tjV7u7MFqZuwsI2a1PZYB5vRmabgSRAntAb37CXO7ZuqteVb5dmEdrMF4UtfbVqDScgTAEw_R9NtNJCSdqiF3t0Nd3U8ffEb7cbINkB76Hw6789B7P1ZvK54crsvJnB5FaA_BEEJL8BLL-K1w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1754524389</pqid></control><display><type>article</type><title>Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Zarpelon, Ana C. ; Rodrigues, Francielle C. ; Lopes, Alexandre H. ; Souza, Guilherme R. ; Carvalho, Thacyana T. ; Pinto, Larissa G. ; Xu, Damo ; Ferreira, Sergio H. ; Alves‐Filho, Jose C. ; McInnes, Iain B. ; Ryffel, Bernhard ; Quesniaux, Valérie F. J. ; Reverchon, Flora ; Mortaud, Stéphane ; Menuet, Arnaud ; Liew, Foo Y. ; Cunha, Fernando Q. ; Cunha, Thiago M. ; Verri, Waldiceu A.</creator><creatorcontrib>Zarpelon, Ana C. ; Rodrigues, Francielle C. ; Lopes, Alexandre H. ; Souza, Guilherme R. ; Carvalho, Thacyana T. ; Pinto, Larissa G. ; Xu, Damo ; Ferreira, Sergio H. ; Alves‐Filho, Jose C. ; McInnes, Iain B. ; Ryffel, Bernhard ; Quesniaux, Valérie F. J. ; Reverchon, Flora ; Mortaud, Stéphane ; Menuet, Arnaud ; Liew, Foo Y. ; Cunha, Fernando Q. ; Cunha, Thiago M. ; Verri, Waldiceu A.</creatorcontrib><description>ABSTRACT
Neuropathic pain from injury to the peripheral and CNS represents a major health care issue. We have investigated the role of IL‐33/IL‐33 receptor (ST2) signaling in experimental models of neuropathic pain in mice. Chronic constriction injury (CCI) of the sciatic nerve induced IL‐33 production in the spinal cord. IL‐33/citrine reporter mice revealed that oligodendrocytes are the main cells expressing IL‐33 within the spinal cord together with a minor expression by neurons, microglia, and astrocytes. CCI‐induced mechanical hyperalgesia was reduced in IL‐33R (ST2)‐/‐ mice compared with wild‐type (WT) mice. Intrathecal treatment of WT mice with soluble IL‐33 receptor (IL‐33 decoy receptor) markedly reduced CCI‐induced hyperalgesia. Consistent with these observations, intrathecal injection of IL‐33 enhanced CCI hyperalgesia and induced hyperalgesia in naive mice. IL‐33‐mediated hyperalgesia during CCI was dependent on a reciprocal relationship with TNF‐α and IL‐1β. IL‐33‐induced hyperalgesia was markedly attenuated by inhibitors of PI3K, mammalian target of rapamycin, MAPKs (p38, ERK, and JNK), NF‐κB, and also by the inhibitors of glial cells (microglia and astrocytes). Furthermore, targeting these signaling pathways and cells inhibited IL‐33‐induced TNF‐α and IL‐1β production in the spinal cord. Our study, therefore, reveals an important role of oligodendrocyte‐derived IL‐33 in neuropathic pain.— Zarpelon, A. C., Rodrigues, F. C., Lopes, A. H., Souza, G. R., Carvalho, T. T., Pinto, L. G., Xu, D., Ferreira, S. H., Alves‐Filho, J. C., McInnes, I. B., Ryffel, B., Quesniaux, V. F. J., Reverchon, F., Mortaud, S., Menuet, A., Liew, F. Y., Cunha, F. Q., Cunha, T. M., Verri, Jr., W. A. Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain. FASEB J. 30, 54‐65 (2016). www.fasebj.org</description><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fj.14-267146</identifier><identifier>PMID: 26310268</identifier><language>eng</language><publisher>United States: The Federation of American Societies for Experimental Biology</publisher><subject>Alarmins - metabolism ; Animals ; Astrocytes - metabolism ; Cellular Biology ; glial cells ; hyperalgesia ; Hyperalgesia - metabolism ; Interleukin-33 - metabolism ; Life Sciences ; MAPK ; Mice, Knockout ; Microglia - metabolism ; mTOR ; Neuralgia - metabolism ; Neurons and Cognition ; NF‐κB ; Oligodendroglia - metabolism ; Pain Threshold - physiology ; Phosphatidylinositol 3-Kinases - metabolism ; Signal Transduction - genetics ; Signal Transduction - physiology ; Spinal Cord - metabolism ; Spinal Cord - physiopathology</subject><ispartof>The FASEB journal, 2016-01, Vol.30 (1), p.54-65</ispartof><rights>FASEB</rights><rights>FASEB.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1096%2Ffj.14-267146$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1096%2Ffj.14-267146$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26310268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03806178$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Zarpelon, Ana C.</creatorcontrib><creatorcontrib>Rodrigues, Francielle C.</creatorcontrib><creatorcontrib>Lopes, Alexandre H.</creatorcontrib><creatorcontrib>Souza, Guilherme R.</creatorcontrib><creatorcontrib>Carvalho, Thacyana T.</creatorcontrib><creatorcontrib>Pinto, Larissa G.</creatorcontrib><creatorcontrib>Xu, Damo</creatorcontrib><creatorcontrib>Ferreira, Sergio H.</creatorcontrib><creatorcontrib>Alves‐Filho, Jose C.</creatorcontrib><creatorcontrib>McInnes, Iain B.</creatorcontrib><creatorcontrib>Ryffel, Bernhard</creatorcontrib><creatorcontrib>Quesniaux, Valérie F. J.</creatorcontrib><creatorcontrib>Reverchon, Flora</creatorcontrib><creatorcontrib>Mortaud, Stéphane</creatorcontrib><creatorcontrib>Menuet, Arnaud</creatorcontrib><creatorcontrib>Liew, Foo Y.</creatorcontrib><creatorcontrib>Cunha, Fernando Q.</creatorcontrib><creatorcontrib>Cunha, Thiago M.</creatorcontrib><creatorcontrib>Verri, Waldiceu A.</creatorcontrib><title>Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><description>ABSTRACT
Neuropathic pain from injury to the peripheral and CNS represents a major health care issue. We have investigated the role of IL‐33/IL‐33 receptor (ST2) signaling in experimental models of neuropathic pain in mice. Chronic constriction injury (CCI) of the sciatic nerve induced IL‐33 production in the spinal cord. IL‐33/citrine reporter mice revealed that oligodendrocytes are the main cells expressing IL‐33 within the spinal cord together with a minor expression by neurons, microglia, and astrocytes. CCI‐induced mechanical hyperalgesia was reduced in IL‐33R (ST2)‐/‐ mice compared with wild‐type (WT) mice. Intrathecal treatment of WT mice with soluble IL‐33 receptor (IL‐33 decoy receptor) markedly reduced CCI‐induced hyperalgesia. Consistent with these observations, intrathecal injection of IL‐33 enhanced CCI hyperalgesia and induced hyperalgesia in naive mice. IL‐33‐mediated hyperalgesia during CCI was dependent on a reciprocal relationship with TNF‐α and IL‐1β. IL‐33‐induced hyperalgesia was markedly attenuated by inhibitors of PI3K, mammalian target of rapamycin, MAPKs (p38, ERK, and JNK), NF‐κB, and also by the inhibitors of glial cells (microglia and astrocytes). Furthermore, targeting these signaling pathways and cells inhibited IL‐33‐induced TNF‐α and IL‐1β production in the spinal cord. Our study, therefore, reveals an important role of oligodendrocyte‐derived IL‐33 in neuropathic pain.— Zarpelon, A. C., Rodrigues, F. C., Lopes, A. H., Souza, G. R., Carvalho, T. T., Pinto, L. G., Xu, D., Ferreira, S. H., Alves‐Filho, J. C., McInnes, I. B., Ryffel, B., Quesniaux, V. F. J., Reverchon, F., Mortaud, S., Menuet, A., Liew, F. Y., Cunha, F. Q., Cunha, T. M., Verri, Jr., W. A. Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain. FASEB J. 30, 54‐65 (2016). www.fasebj.org</description><subject>Alarmins - metabolism</subject><subject>Animals</subject><subject>Astrocytes - metabolism</subject><subject>Cellular Biology</subject><subject>glial cells</subject><subject>hyperalgesia</subject><subject>Hyperalgesia - metabolism</subject><subject>Interleukin-33 - metabolism</subject><subject>Life Sciences</subject><subject>MAPK</subject><subject>Mice, Knockout</subject><subject>Microglia - metabolism</subject><subject>mTOR</subject><subject>Neuralgia - metabolism</subject><subject>Neurons and Cognition</subject><subject>NF‐κB</subject><subject>Oligodendroglia - metabolism</subject><subject>Pain Threshold - physiology</subject><subject>Phosphatidylinositol 3-Kinases - metabolism</subject><subject>Signal Transduction - genetics</subject><subject>Signal Transduction - physiology</subject><subject>Spinal Cord - metabolism</subject><subject>Spinal Cord - physiopathology</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1PwkAQhjdGI4jePJse9VCc_ZpOj2pESUg4oOfN0t3KktLWFjTc_An-Rn-JIOjV0yTvPJlM3oexcw59Dile5_M-V7HAhCs8YF2uJcRICIesC5SKGFFSh5207RwAOHA8Zh2BkoNA6rLxpA6lLaKsalxUFeGlcr50TZWtl_7r49P5Jrx5F9nCNotQRsPRJpQyWngX7NK3UelXTVXb5SxkUW1DecqOclu0_mw_e-x5cP909xiPxg_Du5tRPBMaKeZJym3mrHRWgU4sZcpPUyekRhQEeaIJpAJUpKfWJy7TkClykrzPSatc9tjV7u7MFqZuwsI2a1PZYB5vRmabgSRAntAb37CXO7ZuqteVb5dmEdrMF4UtfbVqDScgTAEw_R9NtNJCSdqiF3t0Nd3U8ffEb7cbINkB76Hw6789B7P1ZvK54crsvJnB5FaA_BEEJL8BLL-K1w</recordid><startdate>201601</startdate><enddate>201601</enddate><creator>Zarpelon, Ana C.</creator><creator>Rodrigues, Francielle C.</creator><creator>Lopes, Alexandre H.</creator><creator>Souza, Guilherme R.</creator><creator>Carvalho, Thacyana T.</creator><creator>Pinto, Larissa G.</creator><creator>Xu, Damo</creator><creator>Ferreira, Sergio H.</creator><creator>Alves‐Filho, Jose C.</creator><creator>McInnes, Iain B.</creator><creator>Ryffel, Bernhard</creator><creator>Quesniaux, Valérie F. J.</creator><creator>Reverchon, Flora</creator><creator>Mortaud, Stéphane</creator><creator>Menuet, Arnaud</creator><creator>Liew, Foo Y.</creator><creator>Cunha, Fernando Q.</creator><creator>Cunha, Thiago M.</creator><creator>Verri, Waldiceu A.</creator><general>The Federation of American Societies for Experimental Biology</general><general>Federation of American Society of Experimental Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>1XC</scope></search><sort><creationdate>201601</creationdate><title>Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain</title><author>Zarpelon, Ana C. ; Rodrigues, Francielle C. ; Lopes, Alexandre H. ; Souza, Guilherme R. ; Carvalho, Thacyana T. ; Pinto, Larissa G. ; Xu, Damo ; Ferreira, Sergio H. ; Alves‐Filho, Jose C. ; McInnes, Iain B. ; Ryffel, Bernhard ; Quesniaux, Valérie F. J. ; Reverchon, Flora ; Mortaud, Stéphane ; Menuet, Arnaud ; Liew, Foo Y. ; Cunha, Fernando Q. ; Cunha, Thiago M. ; Verri, Waldiceu A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h2568-1791acda3da4057a8c4eb9d23566280f75803406485bae7dc50c48d38eef854f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Alarmins - metabolism</topic><topic>Animals</topic><topic>Astrocytes - metabolism</topic><topic>Cellular Biology</topic><topic>glial cells</topic><topic>hyperalgesia</topic><topic>Hyperalgesia - metabolism</topic><topic>Interleukin-33 - metabolism</topic><topic>Life Sciences</topic><topic>MAPK</topic><topic>Mice, Knockout</topic><topic>Microglia - metabolism</topic><topic>mTOR</topic><topic>Neuralgia - metabolism</topic><topic>Neurons and Cognition</topic><topic>NF‐κB</topic><topic>Oligodendroglia - metabolism</topic><topic>Pain Threshold - physiology</topic><topic>Phosphatidylinositol 3-Kinases - metabolism</topic><topic>Signal Transduction - genetics</topic><topic>Signal Transduction - physiology</topic><topic>Spinal Cord - metabolism</topic><topic>Spinal Cord - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zarpelon, Ana C.</creatorcontrib><creatorcontrib>Rodrigues, Francielle C.</creatorcontrib><creatorcontrib>Lopes, Alexandre H.</creatorcontrib><creatorcontrib>Souza, Guilherme R.</creatorcontrib><creatorcontrib>Carvalho, Thacyana T.</creatorcontrib><creatorcontrib>Pinto, Larissa G.</creatorcontrib><creatorcontrib>Xu, Damo</creatorcontrib><creatorcontrib>Ferreira, Sergio H.</creatorcontrib><creatorcontrib>Alves‐Filho, Jose C.</creatorcontrib><creatorcontrib>McInnes, Iain B.</creatorcontrib><creatorcontrib>Ryffel, Bernhard</creatorcontrib><creatorcontrib>Quesniaux, Valérie F. J.</creatorcontrib><creatorcontrib>Reverchon, Flora</creatorcontrib><creatorcontrib>Mortaud, Stéphane</creatorcontrib><creatorcontrib>Menuet, Arnaud</creatorcontrib><creatorcontrib>Liew, Foo Y.</creatorcontrib><creatorcontrib>Cunha, Fernando Q.</creatorcontrib><creatorcontrib>Cunha, Thiago M.</creatorcontrib><creatorcontrib>Verri, Waldiceu A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zarpelon, Ana C.</au><au>Rodrigues, Francielle C.</au><au>Lopes, Alexandre H.</au><au>Souza, Guilherme R.</au><au>Carvalho, Thacyana T.</au><au>Pinto, Larissa G.</au><au>Xu, Damo</au><au>Ferreira, Sergio H.</au><au>Alves‐Filho, Jose C.</au><au>McInnes, Iain B.</au><au>Ryffel, Bernhard</au><au>Quesniaux, Valérie F. J.</au><au>Reverchon, Flora</au><au>Mortaud, Stéphane</au><au>Menuet, Arnaud</au><au>Liew, Foo Y.</au><au>Cunha, Fernando Q.</au><au>Cunha, Thiago M.</au><au>Verri, Waldiceu A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2016-01</date><risdate>2016</risdate><volume>30</volume><issue>1</issue><spage>54</spage><epage>65</epage><pages>54-65</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><abstract>ABSTRACT
Neuropathic pain from injury to the peripheral and CNS represents a major health care issue. We have investigated the role of IL‐33/IL‐33 receptor (ST2) signaling in experimental models of neuropathic pain in mice. Chronic constriction injury (CCI) of the sciatic nerve induced IL‐33 production in the spinal cord. IL‐33/citrine reporter mice revealed that oligodendrocytes are the main cells expressing IL‐33 within the spinal cord together with a minor expression by neurons, microglia, and astrocytes. CCI‐induced mechanical hyperalgesia was reduced in IL‐33R (ST2)‐/‐ mice compared with wild‐type (WT) mice. Intrathecal treatment of WT mice with soluble IL‐33 receptor (IL‐33 decoy receptor) markedly reduced CCI‐induced hyperalgesia. Consistent with these observations, intrathecal injection of IL‐33 enhanced CCI hyperalgesia and induced hyperalgesia in naive mice. IL‐33‐mediated hyperalgesia during CCI was dependent on a reciprocal relationship with TNF‐α and IL‐1β. IL‐33‐induced hyperalgesia was markedly attenuated by inhibitors of PI3K, mammalian target of rapamycin, MAPKs (p38, ERK, and JNK), NF‐κB, and also by the inhibitors of glial cells (microglia and astrocytes). Furthermore, targeting these signaling pathways and cells inhibited IL‐33‐induced TNF‐α and IL‐1β production in the spinal cord. Our study, therefore, reveals an important role of oligodendrocyte‐derived IL‐33 in neuropathic pain.— Zarpelon, A. C., Rodrigues, F. C., Lopes, A. H., Souza, G. R., Carvalho, T. T., Pinto, L. G., Xu, D., Ferreira, S. H., Alves‐Filho, J. C., McInnes, I. B., Ryffel, B., Quesniaux, V. F. J., Reverchon, F., Mortaud, S., Menuet, A., Liew, F. Y., Cunha, F. Q., Cunha, T. M., Verri, Jr., W. A. Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain. FASEB J. 30, 54‐65 (2016). www.fasebj.org</abstract><cop>United States</cop><pub>The Federation of American Societies for Experimental Biology</pub><pmid>26310268</pmid><doi>10.1096/fj.14-267146</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0892-6638 |
ispartof | The FASEB journal, 2016-01, Vol.30 (1), p.54-65 |
issn | 0892-6638 1530-6860 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_03806178v1 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection |
subjects | Alarmins - metabolism Animals Astrocytes - metabolism Cellular Biology glial cells hyperalgesia Hyperalgesia - metabolism Interleukin-33 - metabolism Life Sciences MAPK Mice, Knockout Microglia - metabolism mTOR Neuralgia - metabolism Neurons and Cognition NF‐κB Oligodendroglia - metabolism Pain Threshold - physiology Phosphatidylinositol 3-Kinases - metabolism Signal Transduction - genetics Signal Transduction - physiology Spinal Cord - metabolism Spinal Cord - physiopathology |
title | Spinal cord oligodendrocyte‐derived alarmin IL‐33 mediates neuropathic pain |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T10%3A20%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spinal%20cord%20oligodendrocyte%E2%80%90derived%20alarmin%20IL%E2%80%9033%20mediates%20neuropathic%20pain&rft.jtitle=The%20FASEB%20journal&rft.au=Zarpelon,%20Ana%20C.&rft.date=2016-01&rft.volume=30&rft.issue=1&rft.spage=54&rft.epage=65&rft.pages=54-65&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fj.14-267146&rft_dat=%3Cproquest_hal_p%3E1808690069%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1754524389&rft_id=info:pmid/26310268&rfr_iscdi=true |